PlainRecalls
FDA Drug Moderate Class II Terminated

Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial, Rx Only, Manufactured for: Ingenius Pharmaceuticals, LLC, Orlando, FL 32839-6408; Manufactured by: Ingenius Pharmaceuticals, GmbH Ticino 6917, Switzerland, NDC 50742-401-02.

Reported: July 11, 2018 Initiated: June 8, 2018 #D-0891-2018

Product Description

Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial, Rx Only, Manufactured for: Ingenius Pharmaceuticals, LLC, Orlando, FL 32839-6408; Manufactured by: Ingenius Pharmaceuticals, GmbH Ticino 6917, Switzerland, NDC 50742-401-02.

Reason for Recall

Superpotent Drug: High out of specification assay value results for potency.

Details

Units Affected
14089 vials
Distribution
Nationwide in the USA
Location
Orlando, FL

Frequently Asked Questions

What product was recalled?
Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial, Rx Only, Manufactured for: Ingenius Pharmaceuticals, LLC, Orlando, FL 32839-6408; Manufactured by: Ingenius Pharmaceuticals, GmbH Ticino 6917, Switzerland, NDC 50742-401-02.. Recalled by Ingenus Pharmaceuticals Llc. Units affected: 14089 vials.
Why was this product recalled?
Superpotent Drug: High out of specification assay value results for potency.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 11, 2018. Severity: Moderate. Recall number: D-0891-2018.